Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
8.97
+0.25 (2.87%)
Nov 5, 2024, 1:19 PM EST - Market open

Arcutis Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Market Capitalization
1,0493059011,0431,225-
Upgrade
Market Cap Growth
83.92%-66.18%-13.58%-14.88%--
Upgrade
Enterprise Value
8642836266811,039-
Upgrade
Last Close Price
8.723.2314.8020.7428.13-
Upgrade
PE Ratio
--0.85-2.62-4.97-7.40-
Upgrade
PS Ratio
6.425.11244.56---
Upgrade
PB Ratio
5.453.444.303.504.53-
Upgrade
P/FCF Ratio
-6.08-1.23-3.49-5.94-10.81-
Upgrade
P/OCF Ratio
-6.08-1.23-3.50-5.97-10.84-
Upgrade
EV/Sales Ratio
6.554.74169.88---
Upgrade
EV/EBITDA Ratio
-4.93-1.18-2.08-3.31-7.61-
Upgrade
EV/EBIT Ratio
-4.89-1.17-2.08-3.30-7.61-
Upgrade
EV/FCF Ratio
-4.97-1.14-2.43-3.88-9.17-
Upgrade
Debt / Equity Ratio
1.112.320.970.260.020.00
Upgrade
Debt / FCF Ratio
-1.17-0.83-0.78-0.44-0.04-0.01
Upgrade
Asset Turnover
0.350.150.01---
Upgrade
Inventory Turnover
0.830.48----
Upgrade
Quick Ratio
7.906.3811.0611.6112.6119.36
Upgrade
Current Ratio
8.467.0811.5712.0912.9620.33
Upgrade
Return on Equity (ROE)
-148.92%-175.79%-122.80%-72.62%-72.93%-56.10%
Upgrade
Return on Assets (ROA)
-29.36%-38.12%-43.97%-36.54%-42.15%-34.10%
Upgrade
Return on Capital (ROIC)
-33.11%-42.65%-47.89%-39.67%-45.26%-35.94%
Upgrade
Earnings Yield
-19.50%-85.99%-34.55%-19.78%-11.07%-
Upgrade
FCF Yield
-17.37%-81.18%-28.63%-16.84%-9.25%-
Upgrade
Buyback Yield / Dilution
-61.61%-25.94%-11.39%-38.51%-1835.11%-48.68%
Upgrade
Total Shareholder Return
-61.61%-25.94%-11.39%-38.51%-1835.11%-48.68%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.